These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
    Author: Shiraishi T, Yamamoto T.
    Journal: Pediatr Dermatol; 2013; 30(3):e30-1. PubMed ID: 22304420.
    Abstract:
    Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome.
    [Abstract] [Full Text] [Related] [New Search]